A harm-reduction model of abortion counseling about misoprostol use in Peru with telephone and in-person follow-up: A cohort study

Autor: Jennifer Friedman, Liza Fuentes, Sarah E. Baum, Daniel Grossman, Guadalupe Torres, Denitza Andjelic, Carrie Tatum
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Counseling
Maternal Health
lcsh:Medicine
Abortion
Surveys
Geographical locations
Cohort Studies
0302 clinical medicine
Unsafe abortion
Pregnancy
Peru
Medicine and Health Sciences
030212 general & internal medicine
Young adult
Termination of Pregnancy
lcsh:Science
Misoprostol
Response rate (survey)
030219 obstetrics & reproductive medicine
Multidisciplinary
Obstetrics and Gynecology
Middle Aged
Telephones
Contraception
Research Design
Engineering and Technology
Female
Cohort study
medicine.drug
Research Article
Adult
medicine.medical_specialty
Adolescent
Clinical Research Design
Equipment
Research and Analysis Methods
03 medical and health sciences
Young Adult
Harm Reduction
medicine
Humans
Female Contraception
Communication Equipment
Harm reduction
Abortifacient Agents
Nonsteroidal
Survey Research
business.industry
lcsh:R
South America
medicine.disease
Telephone
Family medicine
Women's Health
lcsh:Q
Adverse Events
People and places
business
Follow-Up Studies
Zdroj: PLoS ONE, Vol 13, Iss 1, p e0189195 (2018)
PLoS ONE
ISSN: 1932-6203
Popis: Background In Peru, abortion is legal only to preserve the life and health of the woman. A non-profit clinic system in Peru implemented a harm-reduction model for women with unwanted pregnancy that included pre-abortion care with instructions about misoprostol use and post-abortion care; they started offering telephone follow-up for clients in 2011. This study aimed to evaluate the effectiveness and safety of the harm-reduction model, and to compare outcomes by type of follow-up obtained. Methods Between January 2012 and March 2013, 500 adult women seeking harm-reduction services were recruited into the study. Telephone surveys were conducted approximately four weeks after their initial harm-reduction counseling session with 262 women (response rate 52%); 9 participants were excluded. The survey focused on whether women pursued an abortion, and if so, what their experience was. Demographic and clinical data were also extracted from clinic records. Results Eighty-six percent of participants took misoprostol; among those taking misoprostol, 89% reported a complete abortion at the time of the survey. Twenty-two percent obtained an aspiration after taking misoprostol and 8% self-reported adverse events including hemorrhage without transfusion, infection, or severe pain. Among women who took misoprostol, 46% reported receiving in-person follow-up (in some cases both telephone and in-person), 34% received telephone only, and 20% did not report receiving any form of follow-up. Those who had in-person follow-up with the counselor were most likely to report a complete abortion (
Databáze: OpenAIRE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje